US Mouth Ulcer Treatment Market

ID: MRFR/Pharma/16446-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Mouth Ulcer Treatment Market Research Report: Size, Share, Trend Analysis By Treatment Type (Topical Treatments, Oral Rinses, Systemic Medications, Home Remedies), By End Users (Hospitals, Clinics, Home Care), By Formulation (Gels, Ointments, Tablets, Mouthwash) and By Age Group (Children, Adults, Elderly) - Growth Outlook & Industry Forecast 2025 To 2035
US Mouth Ulcer Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.65%
2024 Market Size$ 885.97 Million
2025 Market Size$ 909.45 Million
2035 Market Size$ 1,181.32 Million
Key Players
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
Procter & Gamble
Colgate-Palmolive
Mylan
Trends
  • Rise of Natural Remedies
  • E-commerce Expansion
  • Increased Awareness of Oral Health
Opportunities
  • Growing Incidence of Mouth Ulcers
  • Advancements in Treatment Technologies
  • Increased Focus on Preventive Healthcare
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Million)
      1. 4.1.1 Topical Treatments
      2. 4.1.2 Oral Rinses
      3. 4.1.3 Systemic Medications
      4. 4.1.4 Home Remedies
    2. 4.2 Medical Device, BY End User (USD Million)
      1. 4.2.1 Hospitals
      2. 4.2.2 Clinics
      3. 4.2.3 Home Care
    3. 4.3 Medical Device, BY Formulation (USD Million)
      1. 4.3.1 Gels
      2. 4.3.2 Ointments
      3. 4.3.3 Tablets
      4. 4.3.4 Mouthwash
    4. 4.4 Medical Device, BY Age Group (USD Million)
      1. 4.4.1 Children
      2. 4.4.2 Adults
      3. 4.4.3 Elderly
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 GlaxoSmithKline (GB)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bristol-Myers Squibb (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Procter & Gamble (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Colgate-Palmolive (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Mylan (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Sanofi (FR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Reckitt Benckiser (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Haleon (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY END USER
    4. 6.4 US MARKET ANALYSIS BY FORMULATION
    5. 6.5 US MARKET ANALYSIS BY AGE GROUP
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY FORMULATION, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY FORMULATION, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY AGE GROUP, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY AGE GROUP, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY END USER, 2025-2035 (USD Million)
      3. 7.2.3 BY FORMULATION, 2025-2035 (USD Million)
      4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Mouth Ulcer Treatment Market Segmentation

US Mouth Ulcer Treatment Market By Type (USD Million, 2025-2035)

  • Topical Treatments
  • Oral Rinses
  • Systemic Medications
  • Home Remedies

US Mouth Ulcer Treatment Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Clinics
  • Home Care

US Mouth Ulcer Treatment Market By Formulation (USD Million, 2025-2035)

  • Gels
  • Ointments
  • Tablets
  • Mouthwash

US Mouth Ulcer Treatment Market By Age Group (USD Million, 2025-2035)

  • Children
  • Adults
  • Elderly

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.